A retrospective study comparing the efficiency of recurrent LSIL cytology to high-grade cytology as predictors of high-grade cervical intraepithelial neoplasia or worse (CIN2+)

References

• Ferlay J, Colombet M, Soerjomataram I, et al. Estimating the global cancer incidence and mortality in 2018: GLOBOCAN sources and methods. Int J Cancer. 2019;144(8):1941–53.
   PubMed Web of Science ®Google Scholar
• Bray F, Ferlay J, Soerjomataram I, et al. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
   PubMed Web of Science ®Google Scholar
• Lin L, Yan L, Liu Y, et al. Incidence and death in 29 cancer groups in 2017 and trend analysis from 1990 to 2017 from the Global burden of disease study. J Hematol OncolJ Hematol Oncol. 2019;12(1):96.
   PubMed Web of Science ®Google Scholar
• South Africa: Human Papillomavirus and Related Diseases Report. ICO/IARC HPV Information Centre; 2019 Jun.
   Google Scholar
• Catarino R, Petignat P, Dongui G, et al. Cervical cancer screening in developing countries at a crossroad: emerging technologies and policy choices. World J Clin Oncol. 2015;6(6):281–90.
   PubMed Web of Science ®Google Scholar
• Lowy DR, Schiller JT. Reducing HPV-associated cancer globally. Cancer Prev Res (Phila Pa). 2012;5(1):18–23.
   PubMed Web of Science ®Google Scholar
• Meisels A, Fortin R. Condylomatous lesions of the cervix and vagina. I. Cytologic Patterns. Acta Cytol. 1976;20(6):505–9.
   PubMedGoogle Scholar
• Purola E, Savia E. Cytology of gynecologic condyloma acuminatum. Acta Cytol. 1977;21(1):26–31.
   PubMed Web of Science ®Google Scholar
• Ferlay J, Soerjomataram I, Dikshit R, et al. Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012. Int J Cancer. 2015;136(5):E359–386.
   PubMed Web of Science ®Google Scholar
• Denny L, Adewole I, Anorlu R, et al. Human papillomavirus prevalence and type distribution in invasive cervical cancer in sub-Saharan Africa. Int J Cancer. 2014;134(6):1389–98.
   PubMed Web of Science ®Google Scholar
• Strickler HD, Burk RD, Fazzari M, et al. Natural history and possible reactivation of human papillomavirus in human immunodeficiency virus-positive women. J Natl Cancer Inst. 2005;97(8):577–86.
   PubMedGoogle Scholar
• Adler D, Wallace M, Bennie T, et al. High risk human papillomavirus persistence Among HIV-infected young women in South Africa. Int J Infect Dis IJID Off Publ Int Soc Infect Dis. 2015;33:219–21.
   PubMed Web of Science ®Google Scholar
• Moscicki A-B, Ellenberg JH, Vermund SH, et al. Prevalence of and risks for cervical human papillomavirus infection and squamous intraepithelial lesions in adolescent girls: impact of infection With human immunodeficiency virus. Arch Pediatr Adolesc Med. 2000;154(2):127–34.
   PubMedGoogle Scholar
• Serraino D, Dal Maso L, La Vecchia C, et al. Invasive cervical cancer as an AIDS-defining illness in Europe. AIDS Lond Engl. 2002;16(5):781–6.
   PubMed Web of Science ®Google Scholar
• Ezechi OC, Pettersson KO, Okolo CA, et al. The association between HIV infection, antiretroviral therapy and cervical squamous intraepithelial lesions in South western Nigerian women. PLoS ONE. 2014;9(5):e97150.
   PubMed Web of Science ®Google Scholar
• Alves RRF, Rabelo-Santos SH, Ribeiro AA, et al. Usefulness of repeat cytology at the time of first colposcopy. Diagn Cytopathol. 2009;37(1):68–73.
   PubMed Web of Science ®Google Scholar
• Sørbye SW, Arbyn M, Fismen S, et al. Triage of women with low-grade cervical lesions - HPV mRNA testing versus repeat cytology. PLos ONE (Internet). 2011 Aug 30 (cited 2020 Nov 18);6(8). Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3168878/.
   Google Scholar
• Tshomo U, Franceschi S, Tshokey T, et al. Evaluation of cytology versus human papillomavirus-based cervical cancer screening algorithms in Bhutan. Oncotarget. 2017;8(42):72438–46.
   PubMedGoogle Scholar
• Karia N, Van Loon A, Simoens C, et al. The positive predictive value of high-grade squamous intraepithelial lesion on cytology for the histological diagnosis of cervical intraepithelial neoplasia 2 or higher: a systematic review. Acta Cytol. 2019;63(3):206–14.
   PubMed Web of Science ®Google Scholar
• Sultana F, Winch K, Saville M, et al. Is the positive predictive value of high-grade cytology in predicting high-grade cervical disease falling due to HPV vaccination? Int J Cancer. 2019;144(12):2964–71.
   PubMed Web of Science ®Google Scholar
• Boonlikit S. Prevalence of high-grade cervical lesion in women with LSIL and HSIL cytology and prevalence of invasive cancer in women cytologically positive for malignancy. Asia Pac J Cancer Prev. 2008;9(4):715–8.
   PubMedGoogle Scholar
• Benedet JL, Matisic JP, Bertrand MA. An analysis of 84244 patients from the British Columbia cytology-colposcopy program. Gynecol Oncol. 2004;92(1):127–34.
   PubMed Web of Science ®Google Scholar
• Alvarez RD, Wright TC, Optical Detection Group. Effective cervical neoplasia detection with a novel optical detection system: a randomized trial. Gynecol Oncol. 2007;104(2):281–9.
   PubMed Web of Science ®Google Scholar
• Palmer TJ, McFadden M, Pollock KGJ, et al. HPV immunisation and cervical screening—confirmation of changed performance of cytology as a screening test in immunised women: a retrospective population-based cohort study. Br J Cancer. 2016;114(5):582–9.
   PubMed Web of Science ®Google Scholar
• Nygård M, Røysland K, Campbell S, et al. Comparative effectiveness study on human papillomavirus detection methods used in the cervical cancer screening programme. BMJ Open. 2014;4(1):e003460.
   PubMed Web of Science ®Google Scholar
• Ciavattini A, Clemente N, Tsiroglou D, et al. Follow up in women with biopsy diagnosis of cervical low-grade squamous intraepithelial lesion (LSIL): how long should it be? Arch Gynecol Obstet. 2017;295(4):997–1003.
   PubMed Web of Science ®Google Scholar
• Wright TC, Massad LS, Dunton CJ, et al. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. Am J Obstet Gynecol. 2007;197(4):346–55.
   PubMed Web of Science ®Google Scholar
• Boardman LA, Kennedy CM. Management of atypical squamous cells, low-grade squamous intraepithelial lesions, and cervical intraepithelial neoplasia 1. Obstet Gynecol Clin North Am. 2008;35(4):599–614. ix.
   PubMed Web of Science ®Google Scholar
• ASCUS-LSIL Traige Study (ALTS) Group. Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undetermined significance. Am J Obstet Gynecol. 2003;188(6):1383–92.
   PubMed Web of Science ®Google Scholar
• ASCUS-LSIL Traige Study (ALTS) Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol. 2003;188(6):1393–400.
   PubMed Web of Science ®Google Scholar
• Winer RL, Feng Q, Hughes JP, et al. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis. 2008;197(2):279–82.
   PubMed Web of Science ®Google Scholar
• Richter L, Mabaso M, Ramjith J, et al. Early sexual debut: voluntary or coerced? evidence from longitudinal data in South Africa – the birth to twenty plus study. S Afr Med J. 2015;105(4):204–307.
   Google Scholar
• Mbulawa ZZA, Coetzee D, Williamson A-L. Human papillomavirus prevalence in South African women and men according to age and human immunodeficiency virus status. BMC Infect Dis (Internet). 2015 Oct 26 (cited 2020 Nov 24);15. Available from: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4624185/.
   Google Scholar
• Shisana O, Rehle T, Simbayi LC, et al. South African National HIV Prevalence, Incidence and Behaviour Survey, 2012 (Internet). HSRC Press; 2014 (cited 2020 Nov 25). Available from: http://repository.hsrc.ac.za/handle/20.500.11910/2490.
   Google Scholar
• Burger EA, Kim JJ, Sy S, Castle PE. Age of acquiring causal human papillomavirus (HPV) infections: leveraging simulation models to explore the natural history of HPV–induced cervical cancer. Clin Infect Dis. 2017;65(6):893–9.
   Google Scholar
• Makura CBT, Schnippel K, Michelow P, et al. Choropleth mapping of cervical cancer screening in South Africa using healthcare facility-level data from the National Laboratory network. AIMS Public Health. 2016;3(4):849–62.
   PubMed Web of Science ®Google Scholar
• Soncini E, Zoncada A, Condemi V, et al. Reduction of the risk of cervical intraepithelial neoplasia in HIV-infected women treated with highly active antiretroviral therapy. Acta Bio-Medica Atenei Parm. 2007;78(1):36–40.
   PubMedGoogle Scholar
• De Vuyst H, Mugo NR, Chung MH, et al. Prevalence and determinants of human papillomavirus infection and cervical lesions in HIV-positive women in Kenya. Br J Cancer. 2012;107(9):1624–30.
   PubMed Web of Science ®Google Scholar
• Kelly HA, Sawadogo B, Chikandiwa A, et al. Epidemiology of high-risk human papillomavirus and cervical lesions in African women living with HIV/AIDS: effect of anti-retroviral therapy. AIDS Lond Engl. 2017 14;31(2):273–85.
   PubMed Web of Science ®Google Scholar
• McIntyre-Seltman K, Castle PE, Guido R, et al. Smoking Is a risk factor for cervical intraepithelial neoplasia grade 3 among oncogenic human papillomavirus DNA–positive women with equivocal or mildly abnormal cytology. Cancer Epidemiol Prev Biomark. 2005;14(5):1165–70.
   PubMed Web of Science ®Google Scholar
• Westreich D, Jamal N, Smith JS, et al. Injectable and oral contraception and the incidence and progression of cervical disease in HIV-infected women in South Africa. Contraception. 2014;89(4):286–91.
   PubMed Web of Science ®Google Scholar
• International Collaboration of Epidemiological Studies of Cervical Cancer. Cervical carcinoma and reproductive factors: collaborative reanalysis of individual data on 16,563 women with cervical carcinoma and 33,542 women without cervical carcinoma from 25 epidemiological studies. Int J Cancer. 2006;119(5):1108–24.
   PubMed Web of Science ®Google Scholar
• Parazzini F, Chatenoud L, La Vecchia C, et al. Determinants of risk of invasive cervical cancer in young women. Br J Cancer. 1998;77(5):838–41.
   PubMed Web of Science ®Google Scholar
• Samir R, Asplund A, Tot T, et al. Oral contraceptive and progestin-only use correlates to tissue tumor marker expression in women with cervical intraepithelial neoplasia. Contraception. 2012;85(3):288–93.
   PubMed Web of Science ®Google Scholar
• Francis SA, Battle-Fisher M, Liverpool J, et al. A qualitative analysis of South African women’s knowledge, attitudes, and beliefs about HPV and cervical cancer prevention, vaccine awareness and acceptance, and maternal-child communication about sexual health. Vaccine. 2011;29(47):8760–5.
   PubMed Web of Science ®Google Scholar
• De Vuyst H, Franceschi S, Plummer M, et al. Methylation levels of CADM1, MAL, and MIR124-2 in cervical scrapes for triage of HIV-infected, high-risk HPV-positive women in Kenya. J Acquir Immune Defic Syndr 1999. 2015;70(3):311–8.
   PubMed Web of Science ®Google Scholar
• Van Zummeren M, Kremer WW, Van Aardt MC, et al. Selection of women at risk for cervical cancer in an HIV-infected South African population. AIDS Lond Engl. 2017;31(14):1945–53.
   PubMed Web of Science ®Google Scholar